★
PRCT
Procept Biorobotics Corp · Health Care
FCF-$81mF
Rev+29.3%A-
D/E0.15A-
P/S5.1xB
PEG——
63Score
$27.451Y Target$37.06Near-term target
5Y Target$55.21Compound horizon
10Y Target$143.67Long-dated conviction
FCF-$81mTTM · 03/26F
FCF is negative (-$81m) — cash-burning phase; acceptable only for pre-profit spec names · TTM computed from 4 most-recent quarters (TTM · 03/26).
Rev+29.3%TTM YoYA-
Revenue +29.3% — strong growth, well above S&P median (~7%) · TTM YoY from trailing-4-quarter revenue sum vs prior 4 quarters.
D/E0.15totalA-
D/E 0.15 — conservative leverage, strong balance sheet · Total D/E computed from balance sheet (short-term + long-term debt + lease obligations) ÷ stockholders equity. More accurate than native field, which often uses long-term debt only.
P/S5.1xB
P/S 5.1x — in line with software/tech peers
PEG—proxy—
PEG not meaningful — earnings growth negative or data unavailable · PEG proxy: P/E ÷ revenue growth % (true PEG requires forward EPS estimates, not in Finnhub free tier).
Why now
Health Care · market cap $1.6b. Down 59% from 52-week high of $66.85 — deep drawdown territory. Revenue growing +29% — in hypergrowth territory.
Moat
Speculative bucket — the moat thesis is forward-looking; without proven margin structure or capital efficiency yet, the durability argument is about IP / network effects / first-mover position that the company hasn't fully monetized.
Risk
Free cash flow is negative (-$81m) — capital raises or debt issuance likely required; dilution / leverage risk. Currently unprofitable (margin -31.8%) — path to GAAP profitability is the core thesis risk. Down 59% from the 52-week high — the market is pricing in something the screen can't see; verify the bear case before sizing up.
Horizon
1-3 yr $37.06 (structural (no analyst coverage)) — catalyst-driven; binary events dominate. 5 yr $55.21 — requires the platform / technology to reach commercial scale. 10 yr $143.67 — return distribution heavily skewed.
Not investment advice. The Bull Rankings publishes a quantitative ranking model and accompanying analysis for general informational purposes only. Nothing on this page is a recommendation to buy, sell, or hold any security; nothing is personalized to your circumstances, risk tolerance, or tax situation. Investing carries the risk of loss — invest at your own risk and consider consulting a licensed financial professional before acting on anything you read here. See terms and methodology for full disclosures.
Position sizing · PRCT
Shares to buy
72
Position size
$1,976
4.0% of portfolio
Stop price
$20.59
25% below $27.45
$ at risk
$500.00
1% of portfolio
Math only — share count is floor(portfolio × risk% ÷ (price × stop%)). Doesn't account for commissions, slippage, gap risk, or position-correlation across your book. Inputs persist locally; never sent to the server. Not investment advice.